IMMvention Therapeutix
Chapel Hill
About IMMvention Therapeutix
IMMvention Therapeutix is a biotechnology company developing novel small molecule pan-inflammasome inhibitors for treating inflammatory diseases. It has a platform technology where it harnesses the immune system via biodegradable biopolymeric nano/micro-particles. The company's expertise targets auto-inflammatory ailments for which there are large unmet wants, together with rheumatoid arthritis, osteoarthritis, gout, and Alzheimer’s illness. Its illness-modifying therapies inhibit irritation attributable to inflammasomes that activate inflammatory responses. The corporate makes use of its platform to find small-molecule inhibitors of a number of inflammatory receptors.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $9.1M
- Last round: Series Unknown (Jan 2023)
- Website: immventionthera.com
- Phone: 919-593-6230
Industries & Categories
Biotechnology, Health Care, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/immvention-therapeutix-48332 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.